Retina Microvascularisation and Cardiovascular Heart Disease Prediction
1 other identifier
observational
40
1 country
1
Brief Summary
Earlier studies have found that retinal photography could be very useful for evaluating the condition of microcirculation and the risk of cardiovascular diseases in patients. The architectural changes in retinal vascularisation strongly correlates with macrovascular remodeling. Also, recent founding suggests a possible close anatomical parallel between both the macrovascular and the microvascular blood. Our objectives are to assess (1) in which age and sex subgroups, if any, retinal vascular alteration in arterioles and venules can be predictive for cardiovascular morbidity and mortality; and (2) whether variations in arteriolar or venular caliber will predict better cardiovascular pathogenesis in normal and patient population. If the association between the diameter of the retinal vessels and the risks of cardiovascular disease is verified during this study, the impact on prevention would be enormous. The retinal microvascular change could become a powerful biomarker in the early detection of the cardiovascular pathogenesis and death risk
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 7, 2009
CompletedFirst Posted
Study publicly available on registry
December 9, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedOctober 30, 2013
October 1, 2013
2 years
December 7, 2009
October 29, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of a major cardiovascular event or complication, defined as hospitalization, death from coronary heart disease, hypertension, arteriosclerosis, nonfatal non-procedure-related myocardial infarction, or fatal or nonfatal stroke
2 years
Secondary Outcomes (2)
Characterization of any retinal vascular disorders occurring at any time during the study: i. Confirmed by an ophthalmologist examination and either an fundus camera or an mfERGs examination ii. Occurrence of serious ophthalmic event
2 years
Correlation with possible cardiovascular event
2 years
Eligibility Criteria
(50 to 70 years old) with history of coronary heart disease (CHD) or one or more risk factors.
You may qualify if:
- Age between 50 to 70 years old (male/female)
- indication of coronarography within the last 3 month preceding the enrollment
- Patients with history of stroke, heart failure or arteriosclerosis.
- At least one of the following risk factors for cardiovascular complication:
- Hypertension
- Coronary heart disease (CHD)
- Diabetes
- Structural heart disease
- Dyslipidemia
- Obesity
You may not qualify if:
- Patients with a permanent pacemaker or ICD
- Nephrosis or chronic renal failure
- The study interferes with therapeutic or diagnostic procedures
- Patients with inability to consent or comply with follow up requirements
- Patients with glaucoma
- Patients with any retina degeneration disease vascular age-related macular degeneration or any -retina degeneration disease
- Patients who are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Montreal Heart Institutelead
- Fonds de la Recherche en Santé du Québeccollaborator
Study Sites (1)
Montreal Heart Institute, 5000 Belanger Street
Montreal, Quebec, HIT IC8, Canada
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Bernard Thibault, MD
Montreal Heart Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiologist - Electrophysiologist
Study Record Dates
First Submitted
December 7, 2009
First Posted
December 9, 2009
Study Start
September 1, 2009
Primary Completion
September 1, 2011
Study Completion
October 1, 2013
Last Updated
October 30, 2013
Record last verified: 2013-10